| Myalept (metreleptin) / Novelion |
2017-003014-22: Leptin in hepatic lipid metabolism in humans Leptin und der Leberfettsoffwechsel |
|
|
| Ongoing | 2 | 43 | Europe | Myalept, Concentrate and solvent for solution for injection, Myalept | Medical University of Vienna, Medical University of Vienna | lipodystrophy patients, patients after liver transplantation and healthy controls, patients suffering from partial or total disease of fat storage in adipose tissue patients with liver transplanthealthy controls, Diseases [C] - Nutritional and Metabolic Diseases [C18] | | | | |
NCT00085982: Effect of Metreleptin Therapy in the Treatment of Severe Insulin Resistance |
|
|
| Active, not recruiting | 2 | 11 | US | Metreleptin | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Severe Insulin Resistance | 10/19 | 01/30 | | |
NCT05351164: Evaluation of Safety and Efficiency of Metreleptin Treatment for Patients With Multiple Symmetric Lipomatosis (MSL) |
|
|
| Active, not recruiting | 2 | 4 | US | Metreleptin | University of Michigan, Amryt Pharma | Lipomatosis, Multiple Symmetrical | 04/24 | 04/25 | | |
| Not yet recruiting | 2 | 50 | Europe | Metreleptin, Myalept®, Sodium chloride | Gabriella Milos | Anorexia Nervosa | 02/26 | 02/26 | | |
NCT02262806: Compassionate Use of Metreleptin in Previously Treated People With Partial Lipodystrophy |
|
|
| Active, not recruiting | 2 | 30 | US | Metreleptin | National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) | Diabetes, Lipodystrophy, Hyperlipidemia | 07/25 | 07/25 | | |
